• Human astrocytoma tissue was stained with Anti-Glial Fibrillary Acidic Protein (GFAP) (ABT470) Antibody
  • Human cerebrum tissue was stained with Anti-Glial Fibrillary Acidic Protein (GFAP) (ABT470) Antibody

Anti-GFAP antibody (300-432 aa) [ABT470] (STJ190068)

SKU:
STJ190068

Current Stock:
Host: Mouse
Applications: IHC
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Glial fibrillary acidic protein (300-432 aa) is suitable for use in Immunohistochemistry research applications.
Clonality: Monoclonal
Clone ID: ABT470
Conjugation: Unconjugated
Isotype: IgG1k
Formulation: Liquid in PBS pH7.2, 0.03% Proclin 300, with stabilizing protein.
Purification: The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
Dilution Range: IHC-P 1:200-400
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: GFAP
Gene ID: 2670
Uniprot ID: GFAP_HUMAN
Immunogen Region: 300-432 aa
Specificity: The antibody can specifically recognize human GFAP protein.. The antibody was also Predict react with Mouse;Rat
Immunogen: Synthesized peptide derived from the human Glial Fibrillary Acidic Protein at the amino acid range 300-432
Post Translational Modifications Phosphorylated by PKN1.
Function GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.
Protein Name Glial Fibrillary Acidic Protein
Gfap
Database Links Reactome: R-HSA-1251985
Reactome: R-HSA-9613829
Cellular Localisation Cytoplasm
Associated With Intermediate Filaments
Alternative Antibody Names Anti-Glial Fibrillary Acidic Protein antibody
Anti-Gfap antibody
Anti-GFAP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance